FDA Advancements in HER2+ Breast Cancer

Recent years have brought many changes to the treatment of patients with HER2-positive metastatic breast cancer.

Related Content:

VideosBreast Cancer

Distinct Mechanism of Action Makes Plinabulin a Potentially Powerful Therapy in Treating Breast Cancer

Antibiotic Overuse During COVID-19 Pandemic Exacerbates Need for Firmer Prescription Policies, Expert Says

Antibiotic Market Fails to Protect Patients with Cancer, Expert Says